Quarterly Result29 May 2026, 03:16 pm
Vista Pharmaceuticals: Audited FY26 Results Approved
AI Summary
Vista Pharmaceuticals Ltd's board meeting on May 29, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The board also approved the appointment of M/s. LMN & Co., Chartered Accountants, as Internal Auditors for the Financial Year 2026-27. The statutory auditors, M/s. A.M Reddy & D.R. Reddy, issued an audit report with an unmodified opinion on the financial results.
Key Highlights
- Audited financial results for FY26 approved by the board.
- M/s. LMN & Co. appointed as Internal Auditors for FY26-27.
- Auditors issued an unmodified opinion on FY26 financial results.
- Total Income for the year ended March 31, 2026 is ₹571.15 Lakhs.
- Net Profit for the period is ₹(1206.12) Lakhs.
Price Impact
More from VISTAPH